Mattia Bertschi
About Mattia Bertschi
Mattia Bertschi is the Co-founder and CEO of Aktiia, a company that developed the first cuff-less technology for blood pressure monitoring. He has extensive experience in research and development, having previously held senior positions at the Centre Suisse d'Electronique et Microtechnique and the Ecole Polytechnique Fédérale de Lausanne.
Work at Aktiia
Mattia Bertschi serves as the Co-founder and CEO of Aktiia, a company that specializes in innovative blood pressure monitoring technology. Under his leadership since 2018, Aktiia has developed the first cuff-less technology for precise blood pressure monitoring. The platform utilizes AI-powered algorithms to analyze over 300 million data points from more than 60,000 active users globally. Aktiia's CE-marked platform is available in seven European markets and has been approved as a medical device in 44 countries worldwide.
Previous Experience at CSEM SA
Before co-founding Aktiia, Mattia Bertschi worked at the Centre Suisse d'Electronique et Microtechnique (CSEM SA) in Neuchâtel. He held several positions, including Senior R&D Engineer from 2008 to 2010, Section Head from 2011 to 2018, and Project Manager for a brief period in 2010. His roles involved overseeing research and development projects, contributing to advancements in electronics and microtechnology.
Education and Expertise
Mattia Bertschi holds a Master of Science in Electrical Engineering and a Ph.D. in Biomedical Engineering from the École Polytechnique Fédérale de Lausanne (EPFL). His educational background laid the foundation for his expertise in engineering and technology, particularly in the fields of electronics and biomedical applications. He also completed his Federal diploma of maturity at Liceo di Lugano 2, focusing on scientific studies.
Contributions to Hypertension Research
At Aktiia, Mattia Bertschi has been instrumental in advancing the understanding of hypertension and enhancing patient care. His work emphasizes the importance of precise blood pressure monitoring and its implications for tailored healthcare solutions. Through the innovative technology developed at Aktiia, he has contributed to significant breakthroughs in the management of hypertension.